This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Here's What Makes KKR Worth Investing for Solid Long-Term Returns
by Zacks Equity Research
KKR's rising AUM balance and strong organic growth look encouraging. A decent liquidity position is an added advantage.
Why Federated Hermes (FHI) Could Beat Earnings Estimates Again
by Zacks Equity Research
Federated Hermes (FHI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Are Investors Undervaluing Federated Hermes (FHI) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
FHI or BLK: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
FHI vs. BLK: Which Stock Is the Better Value Option?
Buy 5 Investment Management Stocks to Enrich Your Portfolio in 2025
by Nalak Das
These five investment management stocks have strong revenues and earnings growth potential for 2025. these are: BSIG, JHG, SEIC, KKR, FHI.
Is Federated Hermes (FHI) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
FHI vs. BLK: Which Stock Is the Better Value Option?
by Zacks Equity Research
FHI vs. BLK: Which Stock Is the Better Value Option?
5 Reasons to Add Artisan Partners Stock to Your Portfolio Now
by Zacks Equity Research
APAM's solid organic growth and rising AUM look encouraging. A solid balance sheet position is an added advantage.
4 Stocks Trading Near 52-Week High With Room to Rise Further
by Vasundhara Sawalka
Investors target stocks that have been on a bullish run lately. Stocks like SYF, FHI, NCLH and STT are seeing price strength and the momentum is likely to continue.
Is Federated Hermes (FHI) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
BrightSphere Investment Group Inc. (BSIG) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
BrightSphere Investment Group (BSIG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Federated Hermes (FHI) Is Up 2.63% in One Week: What You Should Know
by Zacks Equity Research
Does Federated Hermes (FHI) have what it takes to be a top stock pick for momentum investors? Let's find out.
5 Reasons Why You Should Invest in Federated Stock Right Now
by Zacks Equity Research
FHI's steady AUM growth, along with its solid balance position and impressive capital distribution, makes it a lucrative pick right now.
FHI or BLK: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
FHI vs. BLK: Which Stock Is the Better Value Option?
New Strong Buy Stocks for November 15th
by Zacks Equity Research
FHI, RJF, ASTS, APLD and SPRO have been added to the Zacks Rank #1 (Strong Buy) List on November 15, 2024.
Best Income Stocks to Buy for November 15th
by Zacks Equity Research
RJF, FHI and PX made it to the Zacks Rank #1 (Strong Buy) income stocks list on November 15, 2024.
Best Value Stocks to Buy for November 15th
by Zacks Equity Research
FHI and RJF made it to the Zacks Rank #1 (Strong Buy) value stocks list on November 15, 2024.
Comerica Rewards Shareholders With New Share Repurchase Plan
by Zacks Equity Research
CMA announces an additional 10 million share repurchase authorization to its current buyback program, enhancing shareholders' confidence in the stock.
FHI vs. APO: Which Stock Is the Better Value Option?
by Zacks Equity Research
FHI vs. APO: Which Stock Is the Better Value Option?
Should Value Investors Buy Federated Hermes (FHI) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Federated Hermes Q3 Earnings Beat Estimates, Revenues & AUM Rise Y/Y
by Zacks Equity Research
FHI's third-quarter 2024 results benefit from y/y increases in revenues and AUM.
Federated Hermes (FHI) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Federated Hermes (FHI) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Federated Hermes (FHI) Q3 Earnings Top Estimates
by Zacks Equity Research
Federated Hermes (FHI) delivered earnings and revenue surprises of 15.22% and 0.49%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Unlocking Q3 Potential of Federated Hermes (FHI): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Federated Hermes (FHI) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Federated Hermes (FHI) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Federated Hermes (FHI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.